DISORDERS OF THE HYPOTHALAMUS AND PITUITARY

NATIONAL GUIDELINES

*Inpatient management of cranial diabetes insipidus – Society for Endocrinology Clinical Guidance (published July 2018) https://ec.bioscientifica.com/view/journals/ec/7/7/EC-18-0154.xml

* Apoplexy: Emergency Management of Pituitary Apoplexy in Adult Patients – Society for Endocrinology UK emergency clinical guidance (published in 2016) o http://www.endocrineconnections.com/content/5/5/G12

* Apoplexy: Society for Endocrinology UK Guidelines for the Management of Pituitary Apoplexy (published 2011, reviewed no changes March 2014) o http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2265.2010.03913.x/full

* Dopamine agonists – Society for Endocrinology position statement on the use of dopamine agonists in endocrine disorders o http://www.endocrinology.org/policy/docs/11-11_Dopamine_Agonists.pdf

INTERNATIONAL GUIDELINES

* 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism o https://www.karger.com/Article/FullText/491388

* Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline (published in 2017) o https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2017-00131%20

* Acromegaly – US Endocrine Society clinical practice guideline for the investigation and management of acromegaly (published in 2014) o http://press.endocrine.org/doi/full/10.1210/jc.2014-2700

* Pituitary incidentaloma – US Endocrine Society clinical practice guideline for the evaluation, treatment and follow up of pituitary incidentalomas (published in 2011) o http://press.endocrine.org/doi/pdf/10.1210/jc.2010-1048

* Hyperprolactinaemia – US Endocrine Society clinical practice guideline for the diagnosis and treatment of elevated prolactin levels (published in 2011) o http://press.endocrine.org/doi/pdf/10.1210/jc.2010-1692

* Hormonal Replacement in Hypopituitarism in Adults – A US Endocrine Society clinical practice guideline (published in 2016) o http://press.endocrine.org/doi/10.1210/jc.2016-2118

*Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline (published in 2011) o https://academic.oup.com/jcem/article/96/6/1587/2833853

* European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas (published 2018) o http://www.eje-online.org/content/178/1/G1.full.pdf+html

DISORDERS OF GROWTH AND DEVELOPMENT

NATIONAL GUIDELINES

* Growth hormone therapy in adults with growth hormone deficiency – UK National Institute for Health and Care Excellence (NICE) guidelines for the use of recombinant human growth hormone (somatropin) in adults with growth hormone deficiency (published in 2003) o https://www.nice.org.uk/guidance/ta64

DISORDERS OF THE THYROID

NATIONAL GUIDELINES

*NICE Guidelines Thyroid disease: assessment and management https://www.nice.org.uk/guidance/NG145

* Thyroid Cancer – British Thyroid Association guidelines on the management of thyroid cancer (published in 2014) o http://onlinelibrary.wiley.com/doi/10.1111/cen.12515/pdf

* Primary hypothyroidism – Royal College of Physicians and British Thyroid Association guidelines on the diagnosis and management of primary hypothyroidism (published in 2009) o http://www.british-thyroid-association.org/news/Docs/hypothyroidism_statement.pdf

* Radioactive iodine therapy – Royal College of Physicians guideline on the use of radioiodine in the management of benign thyroid disease (published in 2007) o https://www.rcplondon.ac.uk/sites/default/files/documents/radioiodine-management-benign-thyroid-disease.pdf

* Management of patients with Graves’ orbitopathy: initial assessment, management outside specialised centres and referral pathways – The British Thyroid Association guidelines (published in 2015) o http://www.clinmed.rcpjournal.org/content/15/2/173.full.pdf+html

* Porcine thyroid extract – The British Thyroid Association position statement on the use of Armour Thyroid (published in 2007) o http://www.british-thyroid-association.org/Guidelines/Docs/Armour_nov_07.pdf

* Combined T4/T3 therapy – The British Thyroid Association position statement on the use of combined T4 and T3 therapy (published in 2007) o http://www.british-thyroid-association.org/Guidelines/Docs/Armour_nov_07.pdf

* Thyroid function tests – The British Thyroid Association guidelines for the use of thyroid function tests (published in 2006) o http://www.british-thyroid-association.org/info-for-patients/Docs/TFT_guideline_final_version_July_2006.pdf

INTERNATIONAL GUIDELINES

*European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism (published in 2018) o https://www.karger.com/Article/FullText/490384

* European Thyroid Association Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction (published in 2018) o https://www.karger.com/Article/FullText/486957

* Graves’ orbitopathy – European Group on Graves’ orbitopathy (EUGOGO) consensus statement regarding the management of Graves’ orbitopathy (published in 2008) o http://online.liebertpub.com/doi/abs/10.1089/thy.2007.0315

* European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS o https://www.karger.com/Article/FullText/478927

* European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics o https://www.karger.com/Article/FullText/468519

* European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy  (published in 2016) o https://www.karger.com/Article/FullText/443828

* Thyrotoxicosis – American Thyroid Association and American Association of Clinical Endocrinologists guidelines on the management of hyperthyroidism and thyrotoxicosis (published in 2011) o https://www.aace.com/files/hyper-guidelines-2011.pdf

*The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (published in 2015) o https://www.karger.com/Article/FullText/438750

* 2013 ETA Guideline: Management of Subclinical Hypothyroidism (published 2013) o http://www.eurothyroid.com/files/download/ETA-Guideline-Management-of-Subclinical-Hypothyroidism.pdf

DISORDERS OF THE ADRENAL GLAND

REGIONAL GUIDELINES

*NEN Adrenal incidentaloma guidelines

NATIONAL GUIDELINES

* Society of Endocrinology: Coronavirus advice statement for patients with adrenal insufficiency patients https://www.endocrinology.org/news/item/14050/Coronavirus-advice-statement-for-patients-with-adrenal%2fpituitary-insufficiency

* The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline (published in 2016) o http://press.endocrine.org/doi/10.1210/jc.2015-4061

* Emergency Management of Acute Adrenal Insufficiency (Adrenal Crisis) in Adult Patients, Society for Endocrinology Emergency Guidance (published 2016)  o http://www.endocrineconnections.com/content/5/5/G1

INTERNATIONAL GUIDELINES

* Primary adrenal insufficiency – Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency from the Euradrenal group (published in 2014) o http://onlinelibrary.wiley.com/doi/10.1111/joim.12162/pdf

* European Society of Endocrinology Clinical Practice Guideline on the management of Adrenal Incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors (published in 2023) o http://www.ese-hormones.org/publications/directory/ese-clinical-practice-guideline-on-the-management-of-adrenal-incidentalomas-in-collaboration-with-the-european-network-for-the-study-of-adrenal-tumors/

* Adrenal Incidentaloma – American Association of Clinical Endocrinologists guidelines on the investigation, management and follow up of adrenal incidentaloma (published in 2009) o https://www.aace.com/files/adrenal-guidelines.pdf

* European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma (published in 2016) o http://www.eje-online.org/content/174/5/G1

* Adrenal cancer: European Society for Medical Oncology clinical practice guideline for the management of adrenocortical carcinoma and malignant phaeochromocytoma (published in 2012) o http://annonc.oxfordjournals.org/content/23/suppl_7/vii131.full.pdf+html

* Phaeochromocytoma and paraganglioma – US Endocrine Society guidelines on the diagnosis and treatment of phaeochromocytoma and paraganglioma (published in 2014) o http://press.endocrine.org/doi/pdf/10.1210/jc.2014-1498

* Primary aldosteronism – US Endocrine Society guidelines on the diagnosis and treatment of primary aldosteronism (published in 2016) o https://www.endocrine.org/guidelines-and-clinical-practice/clinical-practice-guidelines/primary-aldosteronism

* Cushing’s Syndrome – US Endocrine Society clinical practice guidelines on the diagnosis and treatment of Cushing’s syndrome (published in 2008) o https://www.endocrine.org/~/media/endosociety/Files/Publications/Clinical%20Practice%20Guidelines/Cushings_Guideline.pdf

DISORDERS OF THE GONADS

NATIONAL GUIDELINES

* Infertility – UK National Institute for Health and Care Excellence (NICE) guidelines for the assessment and treatment of people with fertility problems (published in 2013) o https://www.nice.org.uk/guidance/cg156

* Disorders of sex development – Society for Endocrinology UK guidelines on the evaluation and management of infants with disorders of sex development (published in 2011) o https://www.endocrinology.org/policy/docs/11-07_DisordersOfSexDevelopment.pdf

* Androgen therapy in women – Society for Endocrinology and British Society for Sexual Medicine guidance on the role of androgens in women with sexual problems (published in 2010) o http://www.endocrinology.org/policy/docs/10-12-01_UK%20Guidelines%20Androgens%20Female.pdf

* Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline (published in 2014) o https://academic.oup.com/jcem/article/99/10/3489/2836272

* Menopause: diagnosis and management – UK NICE guidline NG23 (published in 2015) o https://www.nice.org.uk/guidance/ng23

* Menopause practice standards  –  produced by the British Menopause Society (BMS), Royal College of Obstetricians and Gynaecologists (RCOG), Society for Endocrinology (SfE), Faculty of Sexual and Reproductive Health (FSRH), Faculty of Pharmaceutical Medicine (FPM) and the Royal Pharmaceutical Society (RPS) (published 2022) https://onlinelibrary.wiley.com/doi/10.1111/cen.14789

*British Society for Sexual Medicine guidelines on adult testosterone deficiency, with statements for UK practice [published 2017] o http://www.bssm.org.uk/wp-content/uploads/2017/12/guidelines-on-adult-testosterone-deficiency-with-statements-for-uk-practice.pdf

*British Society for Sexual Medicine: Guidelines on the management of erectile dysfunction o https://www.guidelines.co.uk/mens-health/guidelines-on-the-management-of-erectile-dysfunction/247615.articl

INTERNATIONAL GUIDELINES

* Polycystic Ovarian Syndrome – US Endocrine Society clinical practice guideline for the diagnosis and treatment of polycystic ovary syndrome (published in 2013) o http://press.endocrine.org/doi/full/10.1210/jc.2013-2350

* Testosterone in men – US Endocrine Society clinical practice guideline regarding the use of testosterone in adult men with androgen deficiency syndromes (published in 2010) o https://www.endocrine.org/~/media/endosociety/Files/Publications/Clinical%20Practice%20Guidelines/FINAL-Androgens-in-Men-Standalone.pdf

* Transsexual People – US Endocrine Society clinical practice guideline for the management of transsexual people (published in 2009) o https://www.endocrine.org/~/media/endosociety/Files/Publications/Clinical%20Practice%20Guidelines/Endocrine-Treatment-of-Transsexual-Persons.pdf

* Hirsuitism in younger women – US Endocrine Society clinical practice guideline for the evaluation & treatment of hirsutism in premenopausal women (published in 2008) o http://press.endocrine.org/doi/10.1210/jc.2007-2437

* Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting (published 2016) o http://www.eje-online.org/content/177/3/G1.abstract?sid=c8ef2533-854e-4afd-b140-034ddad5e500

DISORDERS OF THE PARATHYROID GLAND, CALCIUM DISORDERS AND BONE

NATIONAL GUIDELINES

* Hypocalcaemia: Emergency Management of Acute Hypocalcaemia in Adult Patients – Society for Endocrinology UK emergency clinical guidance (published in 2016) o http://www.endocrineconnections.com/content/5/5/G7

* Hypercalcaemia: Emergency Management of Acute hypercalcaemia in Adult Patients – Society for Endocrinology UK emergency clinical guidance (published in 2016) o http://www.endocrineconnections.com/content/5/5/G9

* Osteoporosis: risk of fragility fracture – UK National Institute for Health and Care Excellence (NICE) guidelines for the assessment and treatment for people Osteoporosis: assessing the risk of fragility fracture (published in 2012) o https://www.nice.org.uk/guidance/cg146

* Bisphosphonates for treating osteoporosis (published in 2017)  o https://www.nice.org.uk/guidance/ta464

* Denosumab treatment – UK National Institute for Health and Care Excellence (NICE) guidelines for use of Denosumab for the prevention of osteoporotic fractures in postmenopausal women (published in 2010) o http://www.nice.org.uk/guidance/ta204/resources/guidance-denosumab-for-the-prevention-of-osteoporotic-fractures-in-postmenopausal-women-pdf

* Drug therapy for primary prevention of fragility fracture in postmenopausal women – UK National Institute for Health and Care Excellence (NICE) guidelines for use of alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (published in 2008) o http://publications.nice.org.uk/alendronate-etidronate-risedronate-raloxifene-and-strontium-ranelate-for-the-primary-prevention-ta160

* Vitamin D – National Osteoporosis Society UK clinical guideline for vitamin D and bone health (published in 2013) o https://www.nos.org.uk/document.doc?id=1352

INTERNATIONAL GUIDELINES

* European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults (published in 2015) o http://www.eje-online.org/content/173/2/G1

* Osteoporosis in Men – US Endocrine Society clinical practice guideline for the management of osteoporosis in men (published in 2013) o http://press.endocrine.org/doi/full/10.1210/jc.2011-3045

* Primary hyperparathyroidism – American Association of Clinical Endocrinologists position statement on the diagnosis and management of primary hyperparathyroidism (published in 2005) o https://www.aace.com/files/position-statements/hyperparathyroidps.pdf

* Asymptomatic primary hyperparathyroidism – Guidelines from the fourth international workshop for the management of asymptomatic primary hyperparathyroidism summary (published in 2014) o http://press.endocrine.org/doi/abs/10.1210/jc.2014-1413?journalCode=jcem

* Paget’s disease – US Endocrine Society clinical practice guideline for the management of Paget’s disease of bone (published in 2014) o http://press.endocrine.org/doi/full/10.1210/jc.2014-2910

DISORDERS OF WEIGHT AND APPETITE

NATIONAL GUIDELINES

* Obesity: identifcation, assessment and management – NICE UK Guideline CG189 (published in 2014) o https://www.nice.org.uk/guidance/cg189/chapter/1-recommendations

INTERNATIONAL GUIDELINES

* Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Patient – American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery (published in 2013) o https://www.aace.com/files/publish-ahead-of-print-final-version.pdf

* Pediatric Obesity: Assessment, Treatment, and Prevention – An Endocrine Society Clinical Practice Guideline, co-sponsored by the European Society of Endocrinology and the Pediatric Endocrine Society (published in 2017)  o https://academic.oup.com/jcem/article/2965084/Pediatric-Obesity-Assessment-Treatment-and

MISCELLANEOUS ENDOCRINE CONDITIONS

 

REGIONAL GUIDELINES

NEN Hyponatremia algorithm

NATIONAL GUIDELINES

* Emergency Management of Severe Symptomatic Hyponatraemia in Adult Patients, Society of Endocrinology Emergency Guidance (published 2016) o http://www.endocrineconnections.com/content/5/5/G4

INTERNATIONAL GUIDELINES

* Hyponatraemia – European Endocrine Society clinical practice guideline on diagnosis and management of hyponatraemia (published in 2014) o http://dx.doi.org/10.1530/EJE-13-1020

* Hypoglycaemia – US Endocrine Society clinical practice guideline for the evaluation and management of adult hypoglycemic disorders (published in 2009) o http://press.endocrine.org/doi/pdf/10.1210/jc.2008-1410

* Neuroendocrine tumours – European Neuroendocrine Tumour Society consensus guideline for the diagnosis and treatment of NET (published in 2012) o http://www.enets.org/basics.119.html

IMAGING TECHNIQUES IN ENDOCRINOLOGY